Skip to main content

Table 1 Clinical characteristics and treatments according to the type of cancer

From: Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study

 

Uterine cervix

Uterine endometrium

Tube

Ovary

Vagina

P-value

All

78

113

2

68

3

 

Age (years), Median (IQR)

47 (41–56)

60 (52–65)

65 (63–66)

56 (50–62)

58 (50–65)

<0.001

BMI (kg/m2), Median (IQR)

21 (19–23)

23 (29–54)

26 (25–27)

22 (19–24)

22 (21–23)

<0.001

No. of LN, Median (IQR)

39 (29–45)

43 (29–54)

53 (51–54)

44 (34–58)

31 (25–46)

0.038

Extent of lymphadenectomy

 PLA, N (%)

22 (28.2)

15 (13.3)

0(0)

5 (7.4)

1 (33.3)

0.006

 PLA + PALA, N (%)

56 (71.8)

98 (86.7)

2 (100)

63 (92.6)

2 (66.7)

LN metastasis

 Positive, N (%)

11 (14.1)

9 (8)

1 (50)

10 (14.7)

0 (0)

0.196

 Negative, N (%)

67 (85.9)

104 (92)

1 (50)

58 (85.3)

3 (100)

Retroperitoneal suture

 Yes, N (%)

58 (74.4)

82 (72.6)

2 (100)

57 (83.8)

3 (100)

0.372

 No, N (%)

20 (25.6)

31 (27.4)

0 (0)

11 (16.2)

0 (0)

Radiation therapy

 Yes, N (%)

12 (15.4)

5 (4.4)

0 (0)

0 (0)

0 (0)

0.003

 No, N (%)

66 (84.6)

108 (95.6)

2 (100)

68 (100)

3 (100)

Chemotherapy

 Yes, N (%)

53 (67.9)

67 (59.3)

2 (100)

58 (85.3)

2 (66.7)

0.002

 No, N (%)

25 (32.1)

46 (40.7)

0 (0)

10 (14.7)

1 (33.0)

Herbal medicine

 Yes, N (%)

2 (2.6)

5 (4.4)

0 (0)

3 (4.4)

0 (0)

0.872

 No, N (%)

76 (97.4)

108 (95.6)

2 (100)

65 (95.6)

3 (100)

Self-management education

 Yes, N (%)

36 (46.2)

57 (50.4)

1 (50)

26 (38.2)

0 (0)

0.266

 No, N (%)

42 (53.8)

56 (49.6)

1 (50)

42 (61.8)

3 (100)

Infection

 Skin (cellulitis), N (%)

4 (5.1)

9 (8.0)

0 (0)

3 (4.4)

0 (0)

0.809

 Lymphocyst, N (%)

3 (3.8)

6 (5.3)

0 (0)

6 (8.8)

0 (0)

 No, N (%)

71 (91.0)

98 (86.7)

2 (100)

59 (86.8)

3 (100)

Lymphocyst formation

 Yes, N (%)

23 (29.5)

37 (32.7)

1 (50)

32 (47.1)

0 (0)

0.095

 No, N (%)

55 (70.5)

76 (67.3)

1 (50)

36 (52.9)

3 (100)

No. of patients excluded owing to their medical history

 Before surgery

0

0

1

2

0

 

 After surgery

0

4

0

2

0

  1. Definition of abbreviations: IQR Interquartile range, BMI Body mass index, No. Number, LN Lymph node, PLA Pelvic lymphadenectomy, PALA Para-aortic lymphadenectomy